ABAKAVIR/LAMIVUDIN VALE

600MG/300MG TBL FLM 30

SÚKL code 0134924
Name of the product ABAKAVIR/LAMIVUDIN VALE
_MA_MEDICATION_DETAIL_INFO_MED_NAME i ABAKAVIR/LAMIVUDIN VALE
Supplement 600MG/300MG TBL FLM 30
Strenght 600MG/300MG
Pharmaceutical form Film-coated tablet
Package 30
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance LAMIVUDINE (LAMIVUDINUM)
ABACAVIR SULFATE (ABACAVIRI SULFAS)
ATC group J05AR02
ATC group name LAMIVUDIN A ABAKAVIR

Marketing authorisation information

Registration Number 42/ 883/15-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 12. 2019
MA Holder Vale Pharmaceuticals Limited, Clonmel
MA Holder country IRSKO
Actual MA holder Mylan Ireland Limited, Dublin
Actual MA holder country IRSKO

Back to list